BIOPHARMA
ByCan TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…
Is Sanofi Strengthening Its Adult Vaccine Strategy with a $2.2 Billion Dynavax Deal?
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by announcing a $2.2…
Will AI-Powered Prior Authorization Change How Medicare Care Is Delivered?
December 2025 — Medicare is preparing to introduce artificial intelligence–driven prior authorization reviews for certain medical services beginning…
Did 2025 Expose the Breaking Point of America’s Health Care System?
New reflections from healthcare leaders highlight how events in 2025 revealed deep structural weaknesses in the U.S. health…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…
Is Samsung Biologics Set to Expand U.S. Operations with $280 Million GSK Acquisition?
Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug production facility from…
